Abstract
Molecular breast imaging (MBI) is an increasingly recognized nuclear medicine imaging modality to detect breast lesions suspicious for malignancy. Recent advances have allowed the development of tissue sampling of MBI-detected lesions using a single-headed camera (breast-specific gamma imaging system) or a dual-headed camera system (MBI system). In this article, we will review current indications of MBI, differences of the two single- and dual-headed camera systems, the appropriate selection of biopsy equipment, billing considerations, and radiation safety. It will also include practical considerations and guidance on how to integrate MBI and MBI-guided biopsy in the current breast imaging workflow.
Original language | English (US) |
---|---|
Pages (from-to) | 484-491 |
Number of pages | 8 |
Journal | Journal of Breast Imaging |
Volume | 2 |
Issue number | 5 |
DOIs | |
State | Published - 2020 |
Keywords
- Breast biopsy
- Image-guided biopsy
- Molecular breast imaging
- Molecular breast imaging-guided biopsy
ASJC Scopus subject areas
- Radiological and Ultrasound Technology
- Radiology Nuclear Medicine and imaging